[Retracted] Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma

Table 2

Characteristics of enrolled patients.

Characteristics	(%)
Gender
Male	37 (48.1%)
Female	40 (51.9%)
Age (years)
≤50	38 (49.4%)
>50	39 (50.6%)
Tumor site
FPL	37 (48.1%)
TOL	26 (33.8%)
BGT	6 (7.8%)
IL	3 (3.9%)
SCB	5 (6.5%)
WHO pathological grade
III	37 (48.1%)
IV	40 (51.9%)
Clinical treatment
Surgery	38 (49.4%)
Surgery + RT/CRT	39 (50.6%)
Tumor size
<2 cm	5 (6.5%)
2-4 cm	24 (31.2%)
>4 cm	48 (62.3%)
PTE
<1 cm	21 (27.3%)
≥1 cm	56 (72.7%)

Note: FPL: frontal and parietal lobe; TOL: temporal and occipital lobe; BGT: basal ganglia and thalamus area; IL: insular lobe; SCB: subtentorial cerebellum and brainstem; RT: radiotherapy; CRT: chemotherapy and radiotherapy; PTE: peritumoral edema.